Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Charcot-Marie-Tooth disease type 1A News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study quantifies disease progression in patients with Charcot-Marie-Tooth neuropathy type 1A using quantitative muscle MRI and clinical outcomes. This research provides valuable insights into the disease's impact on muscle health and progression.

A proof-of-concept study demonstrates that 3D radiomic texture analysis of quantitative muscle MRI can effectively differentiate between myotonic dystrophy type 1 and Charcot-Marie-Tooth neuropathy type 1A. This advancement may enhance diagnostic accuracy for these conditions.

Not rare diseases news,news about your rare disease.

Earlier

A recent study quantifies disease progression in patients with Charcot-Marie-Tooth neuropathy type 1A using quantitative muscle MRI and clinical outcomes. This research provides valuable insights into the disease's impact on muscle health and progression.

A proof-of-concept study demonstrates that 3D radiomic texture analysis of quantitative muscle MRI can effectively differentiate between myotonic dystrophy type 1 and Charcot-Marie-Tooth neuropathy type 1A. This advancement may enhance diagnostic accuracy for these conditions.

Not rare diseases news,
news about your rare disease.